title: Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
abstract: BACKGROUND
  The association of TN expression, tumour grading and expression of commonly used histopathologic prognostic factors (p53 and estrogen receptor) was examined in 62 cases of invasive ductal carcinoma of the breast.
  
  
  METHODS
  Following histological grading immunohistochemical reactions were undertaken on routine histopathologic samples and the results semiquantitatively evaluated.
  
  
  RESULTS
  Strong TN expression was found in close proximity of the neoplastic epithelial cells in each case, but not in other areas of the stroma. In 10 (16%) cases TN expression was detected to the neoplastic epithelial cells as well. There was no statistically significant difference in the extent of stromal TN immunoreaction between tumours of different grades. A significant difference was found in p53 and estrogen receptor immunoreactions by tumour grade (p = 0.05). TN immunoreaction in the stroma did not correlate with the nuclear expression of p53, Ki-67 and estrogen receptor in the tumour cells.
  
  
  CONCLUSIONS
  TN immunoreactivity does not seem to correlate with currently used prognostic factors. The increased expression of stromal TN in invasive breast ductal carcinomas is an other indicator of possible role played by the extracelular matrix components in cancer development.
authors.affiliation: 2nd Department of Pathology, Semmelweis University of Medicine, Budapest, Hungary. ta@korb2.sote.hu
authors.forename: A M
authors.initials: AM
authors.lastname: Tökés
authors.forename: E
authors.initials: E
authors.lastname: Hortoványi
authors.forename: G
authors.initials: G
authors.lastname: Csordás
authors.forename: J
authors.initials: J
authors.lastname: Kulka
authors.forename: G
authors.initials: G
authors.lastname: Mózes
authors.forename: A
authors.initials: A
authors.lastname: Hatalyák
authors.forename: A
authors.initials: A
authors.lastname: Kádár
mesh_terms: D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D019063:Tenascin / Q000032:analysis* / Q000276:immunology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
chemical_list: D019394:Ki-67 Antigen; D011960:Receptors, Estrogen; D019063:Tenascin; D016159:Tumor Suppressor Protein p53